Prudential Financial Inc Lyell Immunopharma, Inc. Transaction History
Prudential Financial Inc
- $67.5 Billion
- Q1 2025
A detailed history of Prudential Financial Inc transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 48,057 shares of LYEL stock, worth $21,145. This represents 0.0% of its overall portfolio holdings.
Number of Shares
48,057
Previous 48,057
-0.0%
Holding current value
$21,145
Previous $30,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.87 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$7.04 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.64 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.64 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.94 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $109M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...